JP2010515707A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010515707A5 JP2010515707A5 JP2009545182A JP2009545182A JP2010515707A5 JP 2010515707 A5 JP2010515707 A5 JP 2010515707A5 JP 2009545182 A JP2009545182 A JP 2009545182A JP 2009545182 A JP2009545182 A JP 2009545182A JP 2010515707 A5 JP2010515707 A5 JP 2010515707A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- molecule
- use according
- nucleic acid
- dbait32hc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07300728.8 | 2007-01-12 | ||
| EP07300728A EP1944369A1 (en) | 2007-01-12 | 2007-01-12 | Dbait and its standalone uses thereof |
| PCT/EP2008/050265 WO2008084087A2 (en) | 2007-01-12 | 2008-01-11 | Dbait and its standalone uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010515707A JP2010515707A (ja) | 2010-05-13 |
| JP2010515707A5 true JP2010515707A5 (enExample) | 2011-02-17 |
| JP5462632B2 JP5462632B2 (ja) | 2014-04-02 |
Family
ID=38515555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009545182A Expired - Fee Related JP5462632B2 (ja) | 2007-01-12 | 2008-01-11 | Ｄｂａｉｔおよびその単独使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8093366B2 (enExample) |
| EP (2) | EP1944369A1 (enExample) |
| JP (1) | JP5462632B2 (enExample) |
| CN (1) | CN101622351B (enExample) |
| AU (1) | AU2008204486C1 (enExample) |
| CA (1) | CA2673972C (enExample) |
| EA (1) | EA016053B1 (enExample) |
| WO (1) | WO2008084087A2 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104788523B (zh) | 2010-06-22 | 2017-09-08 | 欧恩科斯欧公司 | 用于核酸结合物的具有内涵体溶解剂的优化的体内递送系统 |
| AU2015202211B2 (en) * | 2010-06-22 | 2016-09-01 | Centre National De La Recherche Scientifique | Optimized in vivo delivery system with endosomolytic agents for nucleic acid conjugates |
| EP2527440A1 (en) * | 2011-05-27 | 2012-11-28 | Institut Curie | Cancer treatment by combining DNA molecules mimicking double strand breaks with hyperthermia |
| ES2879434T3 (es) | 2015-07-23 | 2021-11-22 | Inst Curie | Uso de una combinación de molécula Dbait e inhibidores de PARP para tratamiento del cáncer |
| US10821128B2 (en) * | 2016-03-01 | 2020-11-03 | Onxeo | Treatment of cancer by systemic administration of Dbait molecules |
| WO2017186882A1 (en) * | 2016-04-29 | 2017-11-02 | Onxeo | A method of predicting a response to an anti-tumor treatment by means of signal interfering dna molecules |
| WO2018162439A1 (en) | 2017-03-08 | 2018-09-13 | Onxeo | New predictive biomarker for the sensitivity to a treatment of cancer with a dbait molecule |
| KR20200028392A (ko) * | 2017-06-12 | 2020-03-16 | 유니버시티 오브 마이애미 | 질환의 치료를 위한 sting-의존성 활성화제 |
| CN107793468A (zh) * | 2017-06-26 | 2018-03-13 | 上海悦良生物科技有限公司 | 一种检测dna损伤的方法 |
| EP3461488A1 (en) | 2017-09-27 | 2019-04-03 | Onxeo | Combination of a dbait molecule and a hdac inhibitor for treating cancer |
| US20200407720A1 (en) * | 2018-03-13 | 2020-12-31 | Onxeo | A dbait molecule against acquired resistance in the treatment of cancer |
| CN109321585B (zh) * | 2018-09-30 | 2021-08-06 | 山东大学 | 一种利用t4脱氧核糖核酸连接酶提高原核微生物诱变育种效率的方法 |
| MX2021007271A (es) | 2018-12-21 | 2021-07-15 | Onxeo | Nuevas moleculas de acido nucleico conjugado y sus usos. |
| BR112021018168B1 (pt) * | 2019-03-21 | 2023-11-28 | Onxeo | Composição farmacêutica, combinação e kit compreendendo uma molécula dbait e um inibidor de quinase para o tratamento de câncer |
| EP4075980B1 (en) | 2019-12-18 | 2025-07-23 | Stinginn LLC | Substituted 1,2, 4-triazoles and methods of use |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
| US20230095192A1 (en) * | 2020-03-03 | 2023-03-30 | University Of Washington | Synthetic agonists of dna-pk and their use |
| US11897888B1 (en) | 2020-04-30 | 2024-02-13 | Stinginn Llc | Small molecular inhibitors of sting signaling compositions and methods of use |
| TW202210633A (zh) | 2020-06-05 | 2022-03-16 | 法商昂席歐公司 | 用於治療癌症之dbait分子與kras抑制劑的組合 |
| TW202214857A (zh) | 2020-06-19 | 2022-04-16 | 法商昂席歐公司 | 新型結合核酸分子及其用途 |
| US20240294926A1 (en) | 2021-12-16 | 2024-09-05 | Valerio Therapeutics | New conjugated nucleic acid molecules and their uses |
| WO2024240858A1 (en) | 2023-05-23 | 2024-11-28 | Valerio Therapeutics | Protac molecules directed against dna damage repair system and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1526177A1 (en) * | 2003-10-24 | 2005-04-27 | Institut Curie | Nucleic acids useful for triggering tumor cell lethality |
| JP2005247807A (ja) * | 2004-03-08 | 2005-09-15 | Japan Science & Technology Agency | Ｎｓａｉｄを利用した癌治療用組成物 |
| US20060276423A1 (en) * | 2005-04-18 | 2006-12-07 | Rachel Altura | Survivin-directed RNA interference-compositions and methods |
-
2007
- 2007-01-12 EP EP07300728A patent/EP1944369A1/en not_active Withdrawn
-
2008
- 2008-01-11 WO PCT/EP2008/050265 patent/WO2008084087A2/en not_active Ceased
- 2008-01-11 CA CA2673972A patent/CA2673972C/en active Active
- 2008-01-11 US US12/520,961 patent/US8093366B2/en active Active
- 2008-01-11 JP JP2009545182A patent/JP5462632B2/ja not_active Expired - Fee Related
- 2008-01-11 AU AU2008204486A patent/AU2008204486C1/en not_active Ceased
- 2008-01-11 EP EP08701411.4A patent/EP2102343B1/en active Active
- 2008-01-11 CN CN200880002041.7A patent/CN101622351B/zh not_active Expired - Fee Related
- 2008-01-11 EA EA200900989A patent/EA016053B1/ru not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010515707A5 (enExample) | ||
| JP7442574B2 (ja) | Ｌｐａの遺伝子発現の阻害のための組成物及び方法 | |
| JP7174384B2 (ja) | キメラ２重鎖核酸 | |
| US9828601B2 (en) | Compositions for inhibiting checkpoint gene expression and uses thereof | |
| CN106434665B (zh) | 用于抑制乙型肝炎病毒的基因表达的组合物和方法 | |
| ES2673960T3 (es) | Métodos para modular la expresión de un transcrito-1 de adenocarcinoma en pulmón asociado a metástasis (MALAT-1) | |
| JP2007510405A5 (enExample) | ||
| JP2016502858A5 (enExample) | ||
| WO2001048190A2 (en) | Therapeutic uses of lna-modified oligonucleotides | |
| JP2016513976A5 (enExample) | ||
| JP2021527437A (ja) | Ｓｃｎ９ａ発現を調節するためのオリゴヌクレオチド | |
| ES2696828T3 (es) | Inhibidor de telomerasa y gemcitabina combinados para el tratamiento del cáncer | |
| CN105008533A (zh) | 嵌合单链反义多核苷酸和双链反义试剂 | |
| US8153604B2 (en) | CNS-tumor treatment method and composition | |
| JP7021076B2 (ja) | Ｈｉｆ２αの遺伝子発現を阻害する組成物及び方法 | |
| BR122020023854B1 (pt) | Composto compreendendo oligonucleotídeo modificado e seu uso, uso do oligonucleotídeo modificado, composição e seu uso | |
| KR20150004414A (ko) | Kras-관련 질환을 치료하기 위한 유기 조성물 | |
| JP2016523548A (ja) | 成長ホルモン受容体のモジュレータ | |
| JP2007533742A5 (ja) | 癌治療のためのスルビビンオリゴヌクレオチドおよびゲムシタビンを含む組成物 | |
| US20170009230A1 (en) | Compositions for inhibiting dux4 gene expression and uses thereof | |
| WO2021132591A1 (ja) | エクソン５０のスキッピングを誘導するアンチセンス核酸 | |
| JPWO2019181305A1 (ja) | ｓｎｏＲＮＡの発現抑制剤を有効成分とするがん増殖抑制剤 | |
| JP2016180011A (ja) | がんを治療するための試薬および方法 | |
| WO2017143000A1 (en) | Modulators of klk3 erna | |
| JP5781732B2 (ja) | がん抑制ｍｉＲＮＡ |